Zoetis (ZTS) Change in Inventory (2014 - 2026)
Zoetis' (ZTS) quarterly Change in Inventory came in at $114.0 million in Q1 2026, up 34.12% year-on-year from $85.0 million in Q1 2025, and up 976.92% on a QoQ basis from -$13.0 million in Q4 2025.
Zoetis (ZTS) Change in Inventory (2014 - 2026) Analysis & Trends
Zoetis (ZTS) has 13 years of Change in Inventory data on file, last reported at $114.0 million in Q1 2026.
- On a quarterly basis, Change in Inventory rose 34.12% year-over-year to $114.0 million in Q1 2026; TTM through Mar 2026 was $228.0 million, a 744.44% increase from a year earlier, with the FY2025 full-year figure at $199.0 million, up 397.5% from the prior year.
- Change in Inventory for Q1 2026 stood at $114.0 million, up from -$13.0 million in the prior quarter.
- Over the last five years, Change in Inventory for ZTS reached as high as $235.0 million in Q1 2023 and fell as low as -$136.0 million in Q4 2023.
- Historically, Change in Inventory has averaged $70.6 million across 5 years, with a median of $83.0 million in 2025.
- Across the five-year window, Change in Inventory sank 383.33% in 2023 and soared 2300.0% in 2025, its largest moves.
- Year by year, Change in Inventory stood at $48.0 million in 2022, then tumbled by 383.33% to -$136.0 million in 2023, then soared by 46.32% to -$73.0 million in 2024, then jumped by 82.19% to -$13.0 million in 2025, then surged by 976.92% to $114.0 million in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were $114.0 million in Q1 2026, -$13.0 million in Q4 2025, and $44.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114.00 Mn |
| Mar 31, 2026 | 114.00 Mn |
| Dec 31, 2025 | -13.00 Mn |
| Dec 31, 2025 | -13.00 Mn |
| Sep 30, 2025 | 44.00 Mn |
| Sep 30, 2025 | 44.00 Mn |
| Jun 30, 2025 | 83.00 Mn |
| Jun 30, 2025 | 83.00 Mn |
| Mar 31, 2025 | 85.00 Mn |
| Mar 31, 2025 | 85.00 Mn |
| Dec 31, 2024 | -73.00 Mn |
| Dec 31, 2024 | -73.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Jun 30, 2024 | 17.00 Mn |
| Jun 30, 2024 | 17.00 Mn |
| Mar 31, 2024 | 98.00 Mn |
| Mar 31, 2024 | 98.00 Mn |
| Dec 31, 2023 | -136.00 Mn |
| Dec 31, 2023 | -136.00 Mn |